Skip to Main Content

Author Details

Guanglong Jiang
Indiana University School of Medicine
2011
47
19
Jake Y. Chen (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36650133Osteocyte Egln1/Phd2 links oxygen sensing and biomineralization via FGF23.Bone Res2023
37835439Critical Role of Novel O-GlcNAcylation of S550 and S551 on the p65 Subunit of NF-κB in Pancreatic Cancer.Cancers (Basel)2023
37686687Genetic Regulation of Human isomiR Biogenesis.Cancers (Basel)2023
36650133Osteocyte Egln1/Phd2 links oxygen sensing and biomineralization via FGF23.Bone Res2023
37126018Cytochrome P450 Oxidoreductase (POR) Associated with Severe Paclitaxel-Induced Peripheral Neuropathy in Patients of European Ancestry from ECOG-ACRIN E5103.Clin Cancer Res2023
37835439Critical Role of Novel O-GlcNAcylation of S550 and S551 on the p65 Subunit of NF-κB in Pancreatic Cancer.Cancers (Basel)2023
37686687Genetic Regulation of Human isomiR Biogenesis.Cancers (Basel)2023
37126018Cytochrome P450 Oxidoreductase (POR) Associated with Severe Paclitaxel-Induced Peripheral Neuropathy in Patients of European Ancestry from ECOG-ACRIN E5103.Clin Cancer Res2023
34616010Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.Br J Cancer2022
36151116Passage number affects differentiation of sensory neurons from human induced pluripotent stem cells.Sci Rep2022
35357884Reply to K. Nozawa et al.J Clin Oncol2022
36418322A non-coding GWAS variant impacts anthracycline-induced cardiotoxic phenotypes in human iPSC-derived cardiomyocytes.Nat Commun2022
37013054Inhibition of PRMT5 by market drugs as a novel cancer therapeutic avenue.Genes Dis2022
34986146The impact of SBF2 on taxane-induced peripheral neuropathy.PLoS Genet2022
35269880Using VBIM Technique to Discover ARMC4/ODAD2 as a Novel Negative Regulator of NF-κB and a New Tumor Suppressor in Colorectal Cancer.Int J Mol Sci2022
34910554BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer.J Clin Oncol2022
34853435Correction: Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.Br J Cancer2022
34616010Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.Br J Cancer2022
35285940Impact of African ancestry on the relationship between body mass index and survival in an early-stage breast cancer trial (ECOG-ACRIN E5103).Cancer2022
35357884Reply to K. Nozawa et al.J Clin Oncol2022
37013054Inhibition of PRMT5 by market drugs as a novel cancer therapeutic avenue.Genes Dis2022
36418322A non-coding GWAS variant impacts anthracycline-induced cardiotoxic phenotypes in human iPSC-derived cardiomyocytes.Nat Commun2022
36151116Passage number affects differentiation of sensory neurons from human induced pluripotent stem cells.Sci Rep2022
35285940Impact of African ancestry on the relationship between body mass index and survival in an early-stage breast cancer trial (ECOG-ACRIN E5103).Cancer2022
34853435Correction: Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patients.Br J Cancer2022
34910554BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer.J Clin Oncol2022
35269880Using VBIM Technique to Discover ARMC4/ODAD2 as a Novel Negative Regulator of NF-κB and a New Tumor Suppressor in Colorectal Cancer.Int J Mol Sci2022
34986146The impact of SBF2 on taxane-induced peripheral neuropathy.PLoS Genet2022
33289590Methylomic Signatures of High Grade Serous Ovarian Cancer.Epigenetics2021
33923976Profiling of Adipose and Skeletal Muscle in Human Pancreatic Cancer Cachexia Reveals Distinct Gene Profiles with Convergent Pathways.Cancers (Basel)2021
33199491Impact of Body Mass Index on Presence of ctDNA and Disease Recurrence after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: Analysis from BRE12-158.Clin Cancer Res2021
33289590Methylomic Signatures of High Grade Serous Ovarian Cancer.Epigenetics2021
35224144A complex signature network that controls the upregulation of PRMT5 in colorectal cancer.Genes Dis2021
33923976Profiling of Adipose and Skeletal Muscle in Human Pancreatic Cancer Cachexia Reveals Distinct Gene Profiles with Convergent Pathways.Cancers (Basel)2021
35224144A complex signature network that controls the upregulation of PRMT5 in colorectal cancer.Genes Dis2021
33199491Impact of Body Mass Index on Presence of ctDNA and Disease Recurrence after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: Analysis from BRE12-158.Clin Cancer Res2021
32456215Regulation of a PRMT5/NF-κB Axis by Phosphorylation of PRMT5 at Serine 15 in Colorectal Cancer.Int J Mol Sci2020
32241272Highly robust model of transcription regulator activity predicts breast cancer overall survival.BMC Med Genomics2020
32456215Regulation of a PRMT5/NF-κB Axis by Phosphorylation of PRMT5 at Serine 15 in Colorectal Cancer.Int J Mol Sci2020
32985589PRMT5-mediated methylation of YBX1 regulates NF-κB activity in colorectal cancer.Sci Rep2020
32644110Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial.JAMA Oncol2020
32957968Transcription factor expression as a predictor of colon cancer prognosis: a machine learning practice.BMC Med Genomics2020
32560494The Combination of Low Skeletal Muscle Mass and High Tumor Interleukin-6 Associates with Decreased Survival in Clear Cell Renal Cell Carcinoma.Cancers (Basel)2020
32957968Transcription factor expression as a predictor of colon cancer prognosis: a machine learning practice.BMC Med Genomics2020
32985589PRMT5-mediated methylation of YBX1 regulates NF-κB activity in colorectal cancer.Sci Rep2020
32644110Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer: Preplanned Secondary Analysis of the BRE12-158 Randomized Clinical Trial.JAMA Oncol2020
32241272Highly robust model of transcription regulator activity predicts breast cancer overall survival.BMC Med Genomics2020
32560494The Combination of Low Skeletal Muscle Mass and High Tumor Interleukin-6 Associates with Decreased Survival in Clear Cell Renal Cell Carcinoma.Cancers (Basel)2020
31393333Serologic, but Not Genetic, Markers Are Associated With Impaired Anthropometrics at Diagnosis of Pediatric Crohn's Disease.J Pediatr Gastroenterol Nutr2019
31840082Interferon-γ signaling is associated with <i>BRCA1</i> loss-of-function mutations in high grade serous ovarian cancer.NPJ Precis Oncol2019
  • 1 - 50 of 94

Recommended Authors

Daniel J Serie
Mayo Clinic
Career Start Year 2010
Number of shared co-authors 0
Ganiraju C Manyam
the University of Texas MD Anderson Cancer Center
Career Start Year 2009
Number of shared co-authors 0
Qiyuan Li
National Institute of Data Science in Health and Medicine, Xiamen University
Career Start Year 2008
Number of shared co-authors 0
Gabriele Zoppoli
University of Genoa and Ospedale Policlinico San Martino
Career Start Year 2008
Number of shared co-authors 0
Eunjee Lee
Chungnam National University
Career Start Year 2007
Number of shared co-authors 0
Jing Chen
College of Bioinformatics Science and Technology, Harbin Medical University
Career Start Year 2007
Number of shared co-authors 0
Yang Xie
Quantitative Biomedical Research Center
Career Start Year 2007
Number of shared co-authors 0
Chao Cheng
Baylor College of Medicine
Career Start Year 2005
Number of shared co-authors 0
Abul Kalam Azad
University of Dhaka
Career Start Year 2004
Number of shared co-authors 0
Benjamin Haibe-Kains
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2004
Number of shared co-authors 0
Leslie Cope
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 0
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 0
Brooke L Fridley
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2003
Number of shared co-authors 1
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 3
Michael Slifker
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 0
Keyue Ding
Queen's University
Career Start Year 2002
Number of shared co-authors 0
Syed Haider
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 0
Yidong Chen
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 2
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 0
Yan W Asmann
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 0
Hugues Sicotte
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 0
Celine Lefebvre
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 0
Liewei Wang
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 4
Lianbo Yu
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year 1996
Number of shared co-authors 0
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 0
Sudhir Varma
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 0
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 0

Collaborators

Lang Li
Harbin Medical University
Co-authored papers 9
Tatiana Foroud
Indiana University School of Medicine
Co-authored papers 5
Nancy E Davidson
Co-authored papers 4
Daniel L Koller
Indiana University School of Medicine
Co-authored papers 2
Kouros Owzar
Duke University
Co-authored papers 2
Rita Nanda
Co-authored papers 2
Dan-Yu Lin
Co-authored papers 2
Anna Maria Storniolo
Co-authored papers 2
Mark J Ratain
University of Chicago
Co-authored papers 2
Fang Fang
Co-authored papers 2
Susan M Perkins
Indiana University School of Medicine
Co-authored papers 2
Claudine Isaacs
Co-authored papers 2
Howard L McLeod
Center for Precision Medicine and Functional Genomics, Utah Tech University
Co-authored papers 2
Deanna L Kroetz
University of California San Francisco
Co-authored papers 2
Huanmei Wu
Temple University College of Public Health
Co-authored papers 2
Shen Xiang
Novogene Bioinformatics Institute
Co-authored papers 1
Jie Feng
Capital Normal University
Co-authored papers 1
Junshu Xiao
Co-authored papers 1
Tim H-M Huang
University of Texas Health San Antonio (UTHSA)
Co-authored papers 1
Rommie E Amaro
University of California
Co-authored papers 1
Jake Y Chen
Co-authored papers 1
Jun Wu
Co-authored papers 1
Jake Y. Chen (CM4AI)
University of Alabama at Birmingham
Co-authored papers 1
Ping Wan
College of Plant Science and Technology, Beijing University of Agriculture
Co-authored papers 1
Yuan Zhou
Co-authored papers 1
Wei-Zhong Zhao
National Yang-Ming University
Co-authored papers 1
Release 1.2